Cargando…
Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports
Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.
Autores principales: | Choi, So Ron, Kim, Tae Hyung, Eom, Deuk Won, Jung, Ji Wook, Park, Sang Yoong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640626/ https://www.ncbi.nlm.nih.gov/pubmed/36381036 http://dx.doi.org/10.1002/ccr3.6536 |
Ejemplares similares
-
Comparison of remimazolam–remifentanil and propofol–remifentanil during laparoscopic cholecystectomy
por: Lee, Tae Young, et al.
Publicado: (2023) -
Monitored Anesthesia Care Using Remimazolam and Ketamine Combination for Brief Gynecological Surgeries: A Report for Four Cases
por: Choi, Soron, et al.
Publicado: (2023) -
Remimazolam Anesthesia for Thyroid Surgery
por: Nakagawa, Sae, et al.
Publicado: (2023) -
Monitoring of hemodynamic changes during huge cystic lymphangioma resection in a 91‐day‐old infant
por: Kim, Sung Wan, et al.
Publicado: (2021) -
Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
por: Lee, Seung Cheol, et al.
Publicado: (2023)